SHEREE PATEL: Open Payments
NPI 1952623696 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,125 in 58 payments from 11 companies in 2025. Trend: 2023 $909 · 2024 $989 · 2025 $1,125
Food & beverage: $1,125
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 11 | $236 |
| ABBVIE INC. | 14 | $171 |
| Novartis Pharmaceuticals Corporation | 6 | $163 |
| Incyte Corporation | 6 | $120 |
| Lilly USA, LLC | 5 | $114 |
| Botanix SB Inc | 6 | $109 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $62 |
| Janssen Biotech, Inc. | 3 | $61 |
| Amgen Inc. | 3 | $59 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
Products named: DUPIXENT, OPZELURA, SOFDRA, TALTZ, SKYRIZI, Rhapsido, ILUMYA, TREMFYA.
Industry payments across TX — which companies pay providers there.
